A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat

NCT02474589 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

449

Enrollment

INDUSTRY

Sponsor class

Conditions

Smallpox

Interventions

DRUG: tecovirimat
OTHER: Placebo

Sponsor

SIGA Technologies

Collaborators

[object Object]